Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05016648
Other study ID # W20_244#20.270
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 7, 2019
Est. completion date December 30, 2022

Study information

Verified date August 2021
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Nicholaas H. Sperna Weiland, MD PhD
Phone 0031205669111
Email n.h.spernaweiland@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Objective: The objective of this study is to describe the physiology of the cerebral autoregulation over time during extreme low blood pressures (BP). Study design: This is a retrospective data collection study. During the Personalized External Aortic Root Support (PEARS) procedure extreme low blood pressures < 65 mmHg are medically induced. Hemodynamic and neurophysiologic data is for clinic purposes stored. Study population: All patients requiring a PEARS study at the Amsterdam University Medical Centers, location Amsterdam Medical Center (AMC). Investigation: Cerebral parameters during sustained low blood pressures are monitored with the transcranial doppler (TCD) for cerebral blood flow velocity (CBFV), near infrared spectroscopy (NIRS) for cerebral tissue oxygenation (rS02) and the electroencephalography (EEG) for the cerebral activity. Blood pressure waveforms are retrieved from an invasive arterial catheter. Besides, blood gasses during the low blood pressures and cardiac output, measured with a Schwan Ganz catheter are collected as well as electronic health records (EHR) (like age, gender and weight). All these devices are implemented as stated in the clinic protocol. Main study parameters/endpoints: The investigators will describe the cerebral autoregulation (CA) in several ways to retrieve a cut-off or lower limit of the CA where the regulation is either intact or impaired. First the static CA will be created with the mean arterial pressure (MAP) and mean cerebral blood flow (CBFm), second, the CA will be described with the mean flow velocity index (Mx, a method which calculates the correlation between the MAP and CBFm), COX (correlation between MAP and rS02) and with data of the EEG. After retrieval of the cut off or lower limit, the CA below this point will be described over time to check for differences.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 30, 2022
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Planned for a PEARS procedure - Informed consent should be given Exclusion Criteria: - No informed consent

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands AUMC Amsterdam Noord-holland

Sponsors (1)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cerebral autoregulation A mechanism in the brain influenced by the cerebral blood pressure and cerebral blood flow velocity During the entire operation, about 4 hours.
See also
  Status Clinical Trial Phase
Recruiting NCT05706532 - Cardiovascular and Cerebrovascular Control in Healthy Subjects
Not yet recruiting NCT06406842 - Association Between Local Cerebral Oxygenation Monitoring and Postoperative Stroke in Carotid Endarterectomy N/A
Not yet recruiting NCT05670028 - Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization Phase 2
Recruiting NCT05833607 - Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
Completed NCT05681741 - Impact of Cardiopulmonary Bypass Flow on Cerebral Autoregulation N/A
Recruiting NCT04722939 - Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury
Completed NCT04423016 - Transitional Cerebrovascular Reactivity in Very Preterm Infants